https://cdn.specpick.com/images/photonics/kevin_fahey_headshot_150x150@2x.jpg712370
KMLabs has appointed Kevin P. Fahey as the Chief Executive Officer. Dr. Fahey, a proven solutions-oriented executive, will drive the company’s expansion into its next phase of growth, leveraging KMLabs’ unique, advanced technology. He will work with the KMLabs team to develop solutions targeted to key scientific and industrial markets ranging from biological imaging and chemical spectroscopy, through semiconductor and materials applications for the global marketplace.
This important next stage for KMLabs is enabled by a growth-phase equity round with participation from existing investors, including Intel Capital and the Colorado Impact Fund. The funding will support the release of robust versions of KMLabs’ latest high-impact lasers to the scientific and industrial community. Previous investment enabled the company to advance its ultrafast Ti:sapphire and ultrafast fiber laser technologies, as well as the only fully-engineered coherent EUV/VUV high harmonic generation sources. The results of development in recent years have generated class-leading and fully robust solutions within unusually small - laptop-to-tabletop-sized - form factors.
Fahey has over 20 years of proven management experience in the high-tech sector with successful leadership roles where he drove significant growth. He was the VP of Marketing of Xradia, Inc., and VP of Marketing, and then CEO of Carl Zeiss X-ray Microscopy following the acquisition of Xradia by Zeiss. He became the Senior VP, Global Marketing and Market Segments and member of the management board for Carl Zeiss Microscopy, and the Digital Marketing Officer for Carl Zeiss Corporation. Prior to joining Xradia, he was president and CEO of Metrosol, Inc. He was also the Vice President and General Manager of the Fab Market Division of FEI Company. Fahey holds a Ph.D. and an M.S. in Materials Science and Engineering from Stanford University and a B.S. in Physics from the Massachusetts Institute of Technology.
Fahey assumes the reins of KMLabs immediately, while co-founder Henry Kapteyn will assume the role of EVP, CTO and board co-chair along with Merc Mercure. Co-founder and Professor Margaret Murnane will continue on the Board of KMLabs, as well as supporting the organization with technology development. Dr. Sterling Backus continues in his role as chief scientist.